Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Junichiro Nashimoto"'
Autor:
Seina Ohe, Yuji Kubota, Kiyoshi Yamaguchi, Yusuke Takagi, Junichiro Nashimoto, Hiroko Kozuka-Hata, Masaaki Oyama, Yoichi Furukawa, Mutsuhiro Takekawa
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-17 (2022)
Growth factor-induced release of RNA Pol-II promoter-proximal pausing is vital for immediate-early gene expression, but its mechanism remains elusive. Here, the authors reveal roles of ERK and PP2A in this process and their dysregulation in cancer.
Externí odkaz:
https://doaj.org/article/25151774c4324719bb372acd2dd5e18f
Autor:
Shigeto Kaneko, Yui Uto, Kota Sato, Aki Maeda, Yumiko Yoshiki, Tadao Ishida, Jun Sakamoto, Yu Abe, Nobuhiro Tsukada, Junichiro Nashimoto, Yuji Hiragohri, Kiyoshi Okazuka, Mizuki Ogura, Hiroyuki Hamazaki, Kenshi Suzuki
Publikováno v:
Annals of Hematology. 100:2989-2995
Minimal residual disease (MRD)-negative status in multiple myeloma (MM) is associated with favorable outcomes. Although EuroFlow next-generation flow (NGF) is a global standard for MRD detection, its operating cost is high. Therefore, it is desirable
Autor:
Tadao Ishida, Yui Uto, Yu Abe, Kiyoshi Okazuka, Yumiko Yoshiki, Junichiro Nashimoto, Kenshi Suzuki, Nobuhiro Tsukada, Kanji Miyazaki, Kota Sato, Mizuki Ogura
Publikováno v:
European Journal of Haematology. 104:110-115
Objectives Bortezomib with lenalidomide and dexamethasone (VRd) is a standard induction regimen for transplant-eligible patients with newly diagnosed multiple myeloma (NDMM). However, some patients discontinue VRd because of severe adverse events, de
Autor:
Seina, Ohe, Yuji, Kubota, Kiyoshi, Yamaguchi, Yusuke, Takagi, Junichiro, Nashimoto, Hiroko, Kozuka-Hata, Masaaki, Oyama, Yoichi, Furukawa, Mutsuhiro, Takekawa
Publikováno v:
Nature communications. 13(1)
Growth factor-induced, ERK-mediated induction of immediate-early genes (IEGs) is crucial for cell growth and tumorigenesis. Although IEG expression is mainly regulated at the level of transcription elongation by RNA polymerase-II (Pol-II) promoter-pr
Autor:
Mizuki, Ogura, Nobuhiro, Tsukada, Takao, Yogo, Junichiro, Nashimoto, Yui, Uto, Kota, Sato, Kanji, Miyazaki, Yumiko, Yoshiki, Yu, Abe, Kiyoshi, Okazuka, Tadao, Ishida, Kenshi, Suzuki
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 61(11)
Plerixafor is increasingly used in combination with granulocyte-colony-stimulating factor (G-CSF) for peripheral blood stem cell collection. Although it is an expensive drug, its cost-benefit performance is not well investigated. Thus, we analyzed it
Autor:
Kota, Sato, Nobuhiro, Tsukada, Junichiro, Nashimoto, Yui, Uto, Kanji, Miyazaki, Mizuki, Ogura, Yumiko, Yoshiki, Yu, Abe, Kiyoshi, Okazuka, Tadao, Ishida, Kenshi, Suzuki
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 60(12)
Although elotuzumab (ELO) is associated with improved outcomes in patients with relapsed/refractory multiple myeloma (MM), no data are available for the usage of ELO following allogeneic stem cell transplantation (allo-SCT). Here, we report two cases
Autor:
Yumiko, Yoshiki, Nobuhiro, Tsukada, Junichiro, Nashimoto, Takao, Yogo, Yui, Uto, Kota, Sato, Kanji, Miyazaki, Mizuki, Ogura, Yu, Abe, Kiyoshi, Okazuka, Tadao, Ishida, Kenshi, Suzuki
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 60(10)
Because multiple myeloma is rare in young people, there are fewer reports on the same. Thus, its clinical aspects and prognosis remain unelucidated. We retrospectively evaluated 30 patients with multiple myeloma aged ≤ 45 years at diagnosis. We div
Autor:
Takao, Yogo, Nobuhiro, Tsukada, Junichiro, Nashimoto, Yui, Uto, Kota, Sato, Kanji, Miyazaki, Mizuki, Ogura, Yumiko, Yoshiki, Yu, Abe, Kiyoshi, Okazuka, Tadao, Ishida, Kenshi, Suzuki
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 60(3)
Failure of autologous peripheral blood stem cell collection (PBSCH) can affect the treatment modality for patients with hematological malignancies. The clinical efficacy of plerixafor in PBSCH was analyzed in our institution. The medical records of 6
Autor:
Yumiko Yoshiki, Nobuhiro Tsukada, Kota Sato, Yu Abe, Tadao Ishida, Junichiro Nashimoto, Mizuki Ogura, Kanji Miyazaki, Kiyoshi Okazuka, Yui Uto, Takao Yogo, Kenshi Suzuki
Publikováno v:
International journal of hematology. 110(4)
Red blood cell distribution width (RDW) has been used for the differential diagnosis of anemia, but high RDW may also be associated with several human disorders. We evaluated the prognostic relevance of RDW in patients with light-chain (AL) amyloidos
Autor:
Nobuhiro Tsukada, Tadao Ishida, Hirofumi Irita, Kota Sato, Moe Nomura, Kanji Miyazaki, Mizuki Ogura, Kenshi Suzuki, Junichiro Nashimoto, Yu Abe
Publikováno v:
Blood. 136:4-4
BACKGROUND: High dose chemotherapy followed by autologous peripheral blood stem cell transplantation is an effective treatment for multiple myeloma. However, many patients with newly diagnosed multiple myeloma are transplant-ineligible because of the